Related Experiment Video
Updated: Apr 10, 2026
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
Published on: July 12, 2011
Deep Venous Thrombosis with Pulmonary Embolism Related to IVIg Treatment: A Case Report and Literature Review
Michael T Flannery1, Deborah Humphrey1
1University of South Florida Morsani College of Medicine, 12901 Bruce B Downs Boulevard, MDC Box 19, Room L1041, Tampa, FL 33612, USA.
IVIg therapy has potentially been related to arterial and venous therapy. We performed an Ovid review focusing on IVIg and thrombotic events. While a few case reports were reviewed case series and case control studies were particularly reviewed in relation to thrombotic events. Outcomes demonstrate a correlation between underlying cardiovascular risk factors with predominately arterial events which typically occurred within 4-24 hours of infusion. While venous events occurred less commonly they were associated with traditional risk factors and occurred later, typically, 1-7 days following infusion of IVIg. Potential causation of thrombotic events was discussed.
IVIg therapy has potentially been related to arterial and venous therapy. We performed an Ovid review focusing on IVIg and thrombotic events. While a few case reports were reviewed case series and case control studies were particularly reviewed in relation to thrombotic events. Outcomes demonstrate a correlation between underlying cardiovascular risk factors with predominately arterial events which typically occurred within 4-24 hours of infusion. While venous events occurred less commonly they were associated with traditional risk factors and occurred later, typically, 1-7 days following infusion of IVIg. Potential causation of thrombotic events was discussed.
